Archive Newsletter

31. 10.27.25 -- Biotech In Motion: From Mini Bioreactors To Molecular Testing 10/27/2025
    10/27/25 Cell & Gene Newsletter
32. 10.27.25 -- Harness Digital Solutions For Smarter Cell Therapy Manufacturing 10/27/2025

    10/27/25 Cell & Gene Newsletter

33. 10.27.25 -- CDMO Opportunities And Threats Report 10/27/2025
    10/27/25 Cell & Gene Newsletter
34. 10.24.25 -- Flow Cytometry Sample Preparation System 10/24/2025
    10/24/25 Cell & Gene Newsletter
35. 10.24.25 -- BlueRock Advances Cell Therapy For Parkinson's Disease 10/24/2025
    10/24/25 Cell & Gene Newsletter
36. 10.23.25 -- CGT Success Starts With The First Mile 10/23/2025
    10/23/25 Cell & Gene Newsletter
37. 10.22.25 -- Mitigate contamination risk down to the single-particle level. 10/22/2025
    10/22/25 Cell & Gene Newsletter
38. 10.22.25 -- What Changes To FDA And CBER Mean For The Future Of CGT With Daniela Drago 10/22/2025
    10/22/25 Cell & Gene Newsletter
39. 10.21.25 -- Ensure Standardized, Controlled-Rate Freezing For All Cell Types 10/21/2025
    10/21/25 Cell & Gene Newsletter
40. 10.21.25 -- STREAM Edition: How AI And ML Drive iPSC Quality With Aspen Neuroscience's Thorsten Gorba 10/21/2025

    10/21/25 Cell & Gene Newsletter